Objective: Damage to the cerebral tissue structural connectivity associated with amyotrophic lateral sclerosis (ALS), which extends beyond the motor pathways, can be visualized by diffusion tensor imaging (DTI). The effective translation of DTI metrics as biomarker requires its application across multiple magnetic resonance imaging scanners and patient cohorts. A multi-centre study was undertaken to assess structural connectivity in ALS at a large sample size.
INTRODUCTION
The use of advanced magnetic resonance imaging (M RI) techniques, in particular diffusion tensor imaging (DTI) of white matter tracts, has greatly improved the understanding of the in vivo cerebral and spinal neuropathology of the adult neurodegenerative disorder amyotrophic lateral sclerosis (ALS). [1] [2] [3] [4] [5] DTI can quantify the integrity of large white matter tracts in vivo using metrics such as fractional anisotropy (FA). [6] A DTI-based in vivo imaging concept has also been applied to the recently introduced neuropathological staging system, indicating that ALS may disseminate in regional patterns. [7, 8] ALS overlaps with frontotemporal dementia both clinically and pathologically. While the majority of ALS patients do not develop a frank dementia, a large proportion show cognitive impairments on the same spectrum, and DTI has demonstrated extension of white matter changes into frontal and temporal lobes accordingly. [9, 10] Imaging biomarkers are urgently required for future pharmaceutical trials to be used as objective study end-points. The development of robust prognostic and diagnostic markers has become a major research priority in this notoriously heterogeneous disorder. [11, 12] Effective biomarkers, particularly those integrated in therapeutic studies, need to be applicable across multiple international centres that, in case of M RI, may vary in their scanner hardware and sequence acquisition parameters.
The Neuroimaging Society in ALS (www.nisals.org) was established in 2010 and developed a roadmap for the standardisation and harmonisation of advanced M RI data in ALS. [13] The most sensitive cerebral pathology found in cross-sectional M RI studies in ALS patients has been in the white matter tracts, [14] in contrast to the characteristic hippocampal atrophy that largely defines Alzheimer's Disease. To date, there have been few large-scale multi-site DTI studies, and none in ALS. Data analysis of such studies may be hampered by differences in scanning protocols, [15, 16] thus an approach to pool DTI data acquired with different protocols was sought. The objective was to identify ALS induced alterations in the white matter structural connectivity in a large scale patient cohort from multiple sites spread across the world.
To this end, a new strategy has been developed that paves the way to use the large numbers of DTI data sets from local data bases of different study sites for comprehensive large-scale multicentre imaging studies.
METHODS

S ubject populations and scanning protocols
Four-hundred-and-forty-two DTI data sets from patients with ALS (N=253) and control subjects (N=189) from eight ALS-specialist clinic sites (tertiary referral centres) were selected ex post facto for this retrospective study (Dublin, Ireland; Edinburgh, UK; Jena, Germany; M iami, USA; M ilano, Italy; Oxford, UK; Rostock, Germany; Ulm, Germany). Centre specific details, including number of subjects and DTI scanning protocols, are given in Table 1 . Patients' data were randomly selected for inclusion as they were available in the respective data bases of each site. All patients were diagnosed with ALS according to the revised El Escorial criteria [17, 18] 
Ethics statements
Following the NiSALS governance guidelines, all data uploaded to the NiSALS repository were fully deidentified. As a safety measure against accidental disclosure of personal information, the data were run through a deidentification routine again after upload to the repository which followed 
Preprocessing and whole-brain-based voxelwise comparison
Data from each centre were assessed for completeness and, according to an established analysis For the comparison of centres, a study-specific template set (b0 and FA) was created with equal weighting of centres, ALS-patients, and controls; then stereotaxic normalization was performed repeatedly with these equally weighted templates.
Influencing factors of FA maps
Different factors may contribute to the variability of DTI data of control subjects and ALS patients.
Although the precise influence of each source of variation could not be delineated, investigating group FA differences between patients and controls on systematic between-centre differences was used to decide whether pooling across centres was feasible. influence the signal-to-noise-ratio and thus indirectly influence FA-values. Furthermore, centrespecific sources of variability on DTI metrics, e.g. scanner specific variability, environmental noise, specific factors such as scanning time might be present in single centre studies but will only slightly influence comparisons at the group level.
[240] Therefore, a strategy to regress out confounders in a two-step procedure was applied to controls' data.
First, the covariates age, voxel size, TE, number of GD, and B0 were regressed out in FA maps of controls, and a corrected FA-map set consisting of FA maps of all controls was derived (Figure 1) .
Corrections for asymmetrical voxel size were not performed as the orientation of the scans in different sites was not identical. In a second step, comparison of FA maps of controls was performed centrewise and, if the number of significant voxels in the group comparison of controls was below a threshold of 10,000 voxels, centres were merged into centre-clusters. were thenand applied to the FA maps ofdata sets from each centre (Figure 1). [29]
Centrewise pooling of ALS patients' FA maps
For ALS patients' FA maps, the covariates voxel size, age, number of GD, B0field strength, and TE were regressed out with the 3D covariate regression matrices that were derived from the controls'
FA maps and centre clusters were set up according to the classification derived for controls' FA maps. Afterwards, 3D linear correction matrices for centre clusters were applied (Figure 1) 
RESULTS
S ingle-centre voxelwise comparison of FA maps (WBS S )
The whole-brain-based voxelwise analysis of single centres' FA maps without correction of confounding multicentric factors showed FA decreases mainly localized along the CST. From these single-centre analyses, no substantial alterations beyond the CST were detected. Centrewise crosssectional results are provided in Figure 2 .
Voxelwise correction of confounding factors
FA maps of controls showed significant correlations (p < 0.05, corrected for multiple comparisons) to the covariates voxel size, age, number of GD, B0field strength, and TE (S upplementary Figure   1A , upper panel). After regressing out these covariates, only small clusters of significancte correlation to the aforementioned covariates remained. The application of the correction matrices to FA maps of ALS patients also reduced the dependency on the covariates voxel size, age, number of GD, B0field strength, and TE (S upplementary Figure 1A, lower panel) . Centres were merged into centre-clusters. That way centres 3b and 6 form a centre-cluster, and centres 3a, 5, and 7 form the reference centre cluster (S upplementary Figure 1B) . Residual accompanying centre-specific influences in between centre clusters were corrected by 3D linear correction matrices using centre-cluster C as a reference (S upplementary Figure 1C) . WBSS of centre clusters are provided in Figure 2B .
The whole-brain-based analysis was performed both for uncorrected and for corrected FA maps of 253 ALS patients and 189 controls and demonstrated difference maps as displayed in Figure 3 .
Resulting alteration patterns were apparently very similar, but after correction a more symmetric pattern between hemispheres was revealed; furthermore, no FA increase clusters remained and the resulting cluster showed an increased interconnectivity. Group comparison of corrected FA maps showed in total a number of approximately 170,000 voxels significant whereas the group comparison of uncorrected FA maps revealed only approximately 140,000 voxels (Figure 3) . Figure 2A) .. In addition, effect sizes (pvalues) for the different ROIs weare illustrated in S upplementary Figure 2B , separately for the different centres. As for the whole data set, most significant results were observed along the CST for all single centres, followed by clusters in the frontal ROIs and the ROIs in the brainstem.and the hippocampal area.
Multi-site region-of-interest (ROI) analysis of FA maps
Multi-site voxelwise comparison of FA maps (WBS S )
The whole-brain-based analysis was performed for corrected FA maps of 253 ALS patients and 189 controls demonstrated difference maps as displayed in Figure 34 . Differences were connected within one large cluster covering an area of about 1570,000 mm 3 in the white matter p < 0.05, corrected for multiple comparisons; this number of significant voxels was higher than computed by . WBSS of "uncorrected" FA-maps (approx. 140,000 m 3 ). AThe split-half stability test (splitting the eight centres to reach almost a split-half for ALS patients and controls) was performed, comparing the results clusters of centres 03, 04, 06, 07, 08 (128 ALS patients vs. 98 controls) and
the results clusters of centres 01, 02, 05 (125 ALS-patients vs. 91 controls), revealinged a similar number of difference cluster voxels for both groups (Figure 2C) . The split-half test as well as the whole group analysis showed basically the same brain regions to be affected (although with a different number of cluster voxels): Wwith respect to the tract specific analysis, [8] major significances were found along the corticospinal tracts (CST, corresponding to neuropathological stage 1 [7] ), including the "horseshoe" configuration (in coronal slicing) reflecting superior CST and transcallosal interconnecting fibres,[303] frontal involvement including areas crossed by the corticopontine and corticorubral tracts (neuropathological stage 2), and the corticostriatal pathway (pathological stage 3), pathways to brainstem (pontine/rubral involvement, pathological stage 2), and hippocampal areas including the proximal portion of the perforant path (pathological stage 4) ( Figure 43A) .
With the application of more lenient thresholding, a pattern resembling the neuropathological spreading could be demonstrated, beginning with highest significances (corrected p < 0.00005, N=23500) in the upper CST, followed by clusters along the CST (corrected p < 0.00015, N=46000), then including frontal areas (corrected p < 0.0015, N=83500), and, at lowest significances level at (corrected p < 0.005 (N=162200) also including brain stem as well as hippocampal areas ( Figure   43B ). This pattern could also be replicated by uncorrected data with a reduced number of significant results voxels, i.e. at corrected p < 0.00005: N=15300, at corrected p < 0.0005: N=34300, at corrected p < 0.005: N=61600, and at corrected p < 0.05: N=134600 (S upplementary Figure 3) .
Following the theory of spreading patterns that could be expressed by ALS-stages [7, 8] , relations were investigated between the FA values and a clinical disability score, i.e. the ALS-FRS-R. For Common acquisition protocols but involving different subjects were investigated for groupwise FA differences between patients and controls on systematic between-centre differences.
[374] During the pooling process, a number of well-defined parameters that confound the FA results could be regressed out. Nevertheless, to some extent, residual centre-specific FA-influencing factors might be identified. That way, matrices for regressing out FA-influencing factors could be applied in the identical manner to FA-maps of ALS-patients. The comparison between the analysis of corrected and the analysis of uncorrected data showed a difference of about 20% in the number of significant voxels. However, as in this study the ratio patients/controls was approximately equal between the centres, the correction effects were less prominent as it could be expected if the ratio patients/controls had differed more between the centres. Furthermore, this study shows that affectations could be observed at the multicentre level with high subject numbers that would not have been possible to show in single centre studies with low subject numbers.Furthermore, this study shows that at the multicentre level with high subject numbers affectations appeared that would not have been possible to show in single centre studies with low subject numbers.
This methodological framework could easily be adapted to further DTI metrics, e.g. radial, axial, or mean diffusivity.
In summary, this study has demonstrated that it is possible to meaningfully interpret combined DTI data from different M RI manufacturers and software platforms after application of appropriate compensations for centre-specific differences. This might pave the way to repurpose larger numbers of DTI data sets of ALS patients for more clinically comprehensive large-scale multicentric imaging studies.
A limitation of this study compared to other multicentre studies of neurodegenerative diseases (e.g.
the PADDINGTON study in Huntington´s Disease or the Alzheimer's Disease Neuroimaging Initiative (ADNI) [4138, 4239] ) is the heterogeneous nature of DTI data resource in terms of magnetic field strength and acquisition sequence parameters used across the centres. It would be advantageous in a future prospective multi-site study to try to harmonise as many data acquisition sequence parameters as possible. A further potential limitation of the current approach is the limited number of control data sets per centre which may be not homogeneous over centres, and might lead to false or over-correction. However, N=20 (which is the case in seven out of the eight centres) has been a standard control sample size in single-centre studies.[330,403,414] As the ratio patients/controls did not differ strongly between different centres, a systematic centre difference would be averaged out in the multi-site group comparison.
By this multi-centre approach involving DTI datasets from more than 250 patients, it was possible to reveal the in vivo pathoanatomy of ALS non-invasively; the alteration pattern was found to be in agreement with post mortem neuroanatomical studies [3842, 425] represents a framework for mapping ALS-specific white matter tract alterations using DTI, and provides encouragement for its extension to other neurodegenerative diseases. In other diseases with emerging evidence of a consistent pathological pattern of spread,[4550] the white matter tract pathology will be closer to the underlying pathology than clusters of regional atrophy, and thus the DTI metrics have the potential to serve as read-outs and biomarkers of disease and its progression for future clinical trials.
